Advances in Breast Cancer Survival Have Plateaued in the Last Decade
Sep 19, 2018
Survival has increased substantially for young women with breast cancer since 1975, though it has largely reached a plateau since around 2005.
Recent Content
FDA Grants Fast-Track Designation to CX-01 for Acute Myeloid Leukemia
Sep 19, 2018
CX-01, a low-anticoagulant heparin derivative, has demonstrated good rates of complete remission, rapid platelet recovery, and no serious adverse events.
Do Dose-Dense Neoadjuvant Chemo Regimens Improve Responses in Bladder Cancer?
Sep 19, 2018
A dose-dense neoadjuvant chemotherapy regimen yielded higher response rates compared with a standard regimen in a cohort of bladder cancer patients.
Prognostic Value of Low Tumor Burden in Patients With Melanoma
Sep 18, 2018
In this article, we review the role of baseline tumor size in response and survival on traditional and contemporary therapies for the treatment of locoregional and distant melanoma recurrences.
A 57-Year-Old Man With History of Pruritic Rashes
Sep 18, 2018
A 57-year-old man presents with a history of pruritic rashes that have persisted over the last 6 months. What is your diagnosis?
Complications of Androgen Deprivation Therapy in Men With Prostate Cancer
Sep 18, 2018
This article summarizes the key side effects associated with ADT for the treatment of prostate cancer and discusses strategies to optimize management.
The Diagnosis and Management of Retroperitoneal Sarcoma
Sep 18, 2018
Retroperitoneal sarcoma is a rare tumor whose diagnosis and management can be challenging and for which management requires a multidisciplinary team.
Insurance Status Linked with Follicular Lymphoma Outcomes
Sep 18, 2018
A study shows expanding access to care through insurance has the potential to improve outcomes in adults with follicular lymphoma.
Eric Ko on Combining Radiation Therapy With Immunotherapy to Treat Non–Small-Cell Lung Cancer
Sep 18, 2018
ONCOLOGY spoke with Eric Ko, MD, PhD, who recently published a review article with his colleagues on strategies for combining radiation therapy with immunotherapy for the treatment of non–small-cell lung cancer.
COUNTERPOINT: Should Radiation Therapy Be Routinely Used in the Adjuvant Treatment of Stage III Endometrial Cancer?
Sep 18, 2018
The routine use of adjuvant radiation therapy in stage III endometrial cancer patients is not supported by the current literature and should not be employed universally in this group of patients.
